Nejmoa1402551 Nia
Relapsed and Refractory Myeloma Case 2 James R. Berenson, MD Medical & Scientific Director Institute for Myeloma & Bone Cancer Research Los Angeles, CA.
Ravi Vij MD Associate Professor Section of BMT and Leukemia
Update on transplant-ineligible patients: Which regimens are best?
Copyright © 2010, Research To Practice, All rights reserved. Part III: Multiple Myeloma Monday, October 4, 2010 7:30 PM - 8:30 PM ET Monday Night with.
Faculty
Developments in the Treatment of Multiple Myeloma Kenneth C. Anderson, M.D.
1 ANCO ASH Highlights 2007: Multiple Myeloma Joseph M. Tuscano, MD University of California, Davis.
